Eicosapentaenoic Acid clinical trials
Also written EPA.
Counted the way a researcher would: Eicosapentaenoic Acid with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Eicosapentaenoic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Eicosapentaenoic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
56 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 46
S.L.A. Pharma AG (4) · National Science and Technology Council, Taiwan (3) · Massachusetts General Hospital (2) · Mochida Pharmaceutical Company, Ltd. (2) · Tehran University of Medical Sciences (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (2) · William Coryell (2) · CHU de Quebec-Universite Laval (1)
Often tested with
Tested in the same studies.
Docosahexaenoic Acids (9) · Beta-hydroxyisovaleric acid (2) · Flavonoids (1) · Docosapentaenoic acid (1) · Megestrol Acetate (1) · Megestrol (1) · Lutein (1) · Zeaxanthins (1)
Related medicines
As reviewed, each with the page that says it.
- One of Omega-3 fatty acid source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Eicosapentaenoic Acid.
- Mar 2027NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids StatusNot applicable · National Science and Technology Council, Taiwan
- Aug 2027Differential Thrombogenesis by EPA and DHA Mediated by HDLEarly Phase 1 · The Miriam Hospital
Studies
Open first, then newest update. How each study uses Eicosapentaenoic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 56
- Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRacticeRecruitingNot applicableNational Science and Technology Council, TaiwanNCT07462013Written as Eicosapentaenoic acid (omega-3 fatty acid)How we know
- Observing Metabolism of EPA With Consideration of Genetics And SexRecruitingPhase 4University of TorontoNCT06975241Written as EPA 2.4g/dayHow we know
- NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids StatusRecruitingNot applicableNational Science and Technology Council, TaiwanNCT07439744Written as Eicosapentaenoic acid (omega-3 fatty acid)How we know
- Differential Thrombogenesis by EPA and DHA Mediated by HDLRecruitingEarly Phase 1The Miriam HospitalNCT06494488Written as EPAHow we know
- The Developmental Origins of ObesityRecruitingNot applicablePontificia Universidad Catolica de ChileNCT06981676Written as DHA and EPAHow we know
- Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)RecruitingNot applicableUniversity of Eastern PiedmontNCT06928701Written as omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (hexadecenoic acid)How we know
- Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeActive, not recruitingPhase 2CHU de Quebec-Universite LavalNCT02333435Written as EPAHow we know
- The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric SymptomsCompletedNot applicableNational Science and Technology Council, TaiwanNCT07711444Written as Eicosapentaenoic acid (omega-3 fatty acid)How we know
- Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older AdultsCompletedNot applicableOhio State UniversityNCT03576989Written as EPA+DHAHow we know
- Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower OilsActive, not recruitingNot applicableUniversity of Sao PauloNCT07289919Written as EPA capsulesHow we know
- Cardiometabolic Properties of Omega-3 Functionalized With HydroxytyrosolActive, not recruitingNot applicableNational Research Council, SpainNCT06992323Written as EPA + HTHow we know
- Effect of EPA-FFA on Polypectomy in Familial Adenomatous PolyposisActive, not recruitingPhase 3S.L.A. Pharma AGNCT03806426Written as Eicosapentaenoic acid free fatty acid (EPA-FFA)How we know
- Dose Response Effects of Marine Omega-3 Fatty Acids on InflammationCompletedPhase 3Penn State UniversityNCT01078909Written as Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)How we know
- Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaTerminatedPhase 1/2Milton S. Hershey Medical CenterNCT04006847Written as Eicosapentaenoic AcidHow we know
- Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized ApproachCompletedPhase 2/3Massachusetts General HospitalNCT02553915Written as EPA 1 g/dayHow we know
- Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate ThresholdTerminatedPhase 4Samuel FortinNCT03915535Written as Eicosapentaenoic acid + Docosahexaenoic acidHow we know
- EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)Status unknownPhase 3S.L.A. Pharma AGNCT04335032Written as Eicosapentaenoic acid gastro-resistant capsulesHow we know
- Long-term Safety and Efficacy Study of MND-2119 in Patients With HypertriglyceridemiaCompletedPhase 3Mochida Pharmaceutical Company, Ltd.NCT04221217Written as IcosapentHow we know
- The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild DementiaCompletedNot applicableTaichung Veterans General HospitalNCT04972643Written as EPAHow we know
- Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and LipidsCompletedNot applicableTufts UniversityNCT02670382Written as EPAHow we know
See all 56 studies that test Eicosapentaenoic Acid →
Given beside what is tested · 2 — Eicosapentaenoic Acid is usual care or a partner of the new treatment
- Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body CompositionCompletedNot applicableNational Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT01251887Written as Eicosapentaenoic AcidHow we know
- Omega-3 Fatty Acid Deficiency Replacement in Early SchizophreniaCompletedPhase 2/3University of CincinnatiNCT00585390Written as EPA fish oil concentrate; DHA fish oil concentrateHow we know
As the comparator · 3 — what is tested is compared with Eicosapentaenoic Acid
- Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT TrialCompletedPhase 4Kobe UniversityNCT03192579Written as EPA and high dose rosuvastatinHow we know
- Long-term Efficacy and Safety Study of TAK-085 in Participants With HypertriglyceridemiaCompletedPhase 3TakedaNCT01350999Written as Eicosapentaenoic acid-ethyl (EPA)How we know
- Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood CellsCompletedNot applicableSolae, LLCNCT01038440Written as EPAHow we know
Codes
What other systems call Eicosapentaenoic Acid · ClinicalTrials.gg INT008440
- MeSH (NLM) D015118Eicosapentaenoic AcidConfirmed NLM, Wikidata
- UNII (FDA) AAN7QOV9EAICOSAPENTConfirmed FDA, NLM, Wikidata
- RxNorm 90Confirmed FDA, Wikidata
- Wikidata Q409990eicosapentaenoic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C68434IcosapentConfirmed FDA, Wikidata
- DrugBank DB00159One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015118 | Eicosapentaenoic Acid | Confirmed NLM, Wikidata |
| UNII (FDA) | AAN7QOV9EA | ICOSAPENT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 90 | — | Confirmed FDA, Wikidata |
| Wikidata | Q409990 | eicosapentaenoic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C68434 | Icosapent | Confirmed FDA, Wikidata |
| DrugBank | DB00159 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.